Detalhe da pesquisa
1.
The effect of renal function on the pharmacokinetics and pharmacodynamics of enavogliflozin, a potent and selective sodium-glucose cotransporter-2 inhibitor, in type 2 diabetes.
Diabetes Obes Metab
; 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38618974